CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 116 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06934993
NCT06934993N/ACompleted

Comparison of Bidirectional Palpation Test and Transit Time Flow Measurement for LIMA-LAD Graft Patency

Abdulgani Orhun YENİGÜN·observational·Posted Apr 18, 2025·Updated Jul 8, 2025

In Brief

An observational study for Coronary Arterial Disease (CAD) and 7 related conditions. Completed, enrolled 116 participants across 1 site.

Detailed Summary

The most important factor determining mortality and morbidity after coronary artery bypass graft (CABG) surgery is graft patency. The LIMA-LAD anastomosis is the most crucial anastomosis because it's revascularizing the most important and large region of the heart, has superior long-term graft patency rates and is considered the gold standard for CABG. Therefore, ensuring the patency of the LIMA-LAD anastomosis is vital for both early and late outcomes. The bidirectional palpation test (BPT), developed in our clinic to assess graft patency, is a subjective test, yet it is simple and reliable. Additionally, transit time flow meter (TTFM) measurements have also been performed. In this study, the efficacy of BPT and the results of TTFM measurements were compared by examining graft patency through early-period coronary CT angiography (CCTA).

Study Details

Timeline

N/ACompletedFinished
202420252026
First PostedApr 18, 2025
Enrollment StartAug 31, 2023
Primary CompletionAug 27, 2024
Study CompletionSep 14, 2024
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 1.2 years ago